WallStreetZenWallStreetZen

NASDAQ: APTO
Aptose Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

APTO earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$51.2M
Current Profit Margin
0%

APTO Return on Equity

Current Company
-458.7%
Current Industry
-63.5%
Current Market
188%
APTO's Return on Equity (-458.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when APTO announces earnings.

APTO Return on Assets

Current Company
-205.3%
Current Industry
2.9%
APTO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

APTO Return on Capital Employed

Current Company
2,245.92%
Current Industry
19.5%
APTO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

APTO vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
APTO$0.00-$50.74M-$51.21MN/AN/A
GLTO$0.00-$37.52M-$38.35MN/AN/A
BIOR$4.00k-$113.84M-$124.12M-87.44%N/A
PHGE$0.00-$22.87M-$26.17MN/AN/A
BIVI$0.00-$39.04M-$43.27MN/AN/A
View Top Biotech Stocks

APTO earnings dates

Next earnings date
May 28, 2024

Aptose Biosciences Earnings & Revenue FAQ

What were APTO's earnings last quarter?

On Invalid Date, Aptose Biosciences (NASDAQ: APTO) reported Q4 2023 earnings per share (EPS) of -$1.44, up 11.66% year over year. Total Aptose Biosciences earnings for the quarter were -$11.96 million. In the same quarter last year, Aptose Biosciences's earnings per share (EPS) was -$1.63.

If you're new to stock investing, here's how to buy Aptose Biosciences stock.

What was APTO's earnings growth in the past year?

As of Q2 2024, Aptose Biosciences's earnings has grown year over year. Aptose Biosciences's earnings in the past year totalled -$51.21 million.

What is APTO's earnings date?

Aptose Biosciences's earnings date is Invalid Date. Add APTO to your watchlist to be reminded of APTO's next earnings announcement.

What was APTO's revenue last quarter?

On Invalid Date, Aptose Biosciences (NASDAQ: APTO) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Aptose Biosciences's revenue was $0.00.

What was APTO's revenue growth in the past year?

As of Q2 2024, Aptose Biosciences's revenue has grown null year over year. Aptose Biosciences's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.